Avalyn Pharma Inc. (AVLN)
Market Closed
10 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
34. 56
+0.64
+1.8868%
$
1.53B Market Cap
- P/E Ratio
- Div Yield
130,354 Volume
- Eps
$ 33.92
Previous Close 
Want to track AVLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead
Avalyn Pharma NASDAQ: AVLN executives outlined the company's inhaled pulmonary fibrosis strategy at the Jefferies Global Healthcare Conference, emphasizing its recent IPO, ongoing mid-stage studies and plans to position its candidates as potential backbone therapies for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.
Marketbeat | 2 months ago
